Active Runners: Nu Skin Enterprises, Inc. (NYSE:NUS)
Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) dropped -7.452% in morning trade Monday, after a Chinese government website declared a crackdown on pyramid schemes.
The State Administration for Industry & Commerce of the People’s Republic of China website posted a statement in Chinese. A translation in Google showed that the statement said the government was launching a three-month campaign against recruitment by pyramid sellers. (Source: Reuters)
The stock closed the last trade at $56.008, exchanging hands with 2902381 shares contrast to its average daily volume of 512.17K shares. Trading volume is an important technical indicator a shareholder uses to confirm a trend or trend reversal. It is generally higher when the price of a security is changing, as the strength of any given price movement is measured mainly by the volume and shifts in trade volume can make observed price movements more significant. News about a company’s financial status, products, or plans, whether positive or negative, will typically result in a temporary increase in the trade volume of its stock. Higher volume for a stock is also an indicator of higher liquidity in the market. For institutional shareholders who wish to sell a large number of shares of a certain stock, lower liquidity will force them to sell the stock slowly over a longer period of time, to avoid losses because of slippage.
Stock’s Performance Analysis (Weekly, Monthly & Year to Date):
The stock, as of recent close, has shown weekly downbeat performance of -9.161% which was maintained at -11.18% in 1-month period, and is up 17.21% in this year. The company now has a market value of $2.97B.
Stock’s Technical Analysis:
In taking a look at technical levels, shares is trading -10.9% away from the 20-days simple moving average and 1.48% away from the 200-days simple moving average. Based on a recent bid, the stock is trading -15.19% away from its 52-week high and 20.84% away from its 52 week low. 82.96% shares of the company were owned by institutional investors. The company has 1.361 values in price to sale ratio while price to book ratio was recorded as 4.24. It beta stands at 1.4.
Analysts’ Suggestions in the Limelight:
The stock received analysts’ mean target price of $63. This is the projected price level of a financial security stated by an investment analyst or advisor. Shareholders can make better decisions if they focus on target prices, which convey more information for evaluating the potential risk/reward profile of a stock. However, analysts’ mean recommendation for this stock stands at 2.70. Analyst recommendations as stated on FINVIZ are rated on a 1 to 5 scale. 1 is equivalent to a buy rating, 3 a hold rating, and 5 a sell rating. The consensus recommendation is the average rating on a stock by the analyst community.
